Michael Yee
Stock Analyst at UBS
(3.50)
# 2,267
Out of 4,598 analysts
1328
Total ratings
46.7%
Success rate
2.8%
Average return
Main Sectors:
Stocks Rated by Michael Yee
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| BMY Bristol-Myers Squibb Company | Maintained: Buy | $70 → $80 | $65.47 | +22.19% | 4 | Jul 31, 2026 | |
| BIIB Biogen | Maintained: Buy | $225 → $240 | $201.82 | +18.92% | 172 | Jul 30, 2026 | |
| GILD Gilead Sciences | Maintained: Buy | $175 | $131.15 | +33.44% | 188 | Jul 28, 2026 | |
| VRTX Vertex Pharmaceuticals | Maintained: Buy | $585 | $470.72 | +24.28% | 126 | Jul 28, 2026 | |
| MBX MBX Biosciences | Reiterated: Buy | $60 → $90 | $64.41 | +39.73% | 6 | Jul 24, 2026 | |
| AMGN Amgen | Rated: Buy | $400 → $420 | $378.87 | +10.86% | 186 | Jul 13, 2026 | |
| LLY Eli Lilly and Company | Rated: Buy | $1,250 → $1,425 | $1,121.36 | +27.08% | 7 | Jul 13, 2026 | |
| ABBV AbbVie | Rated: Hold | $230 → $260 | $245.10 | +6.08% | 6 | Jul 13, 2026 | |
| RVMD Revolution Medicines | Reiterated: Buy | $175 → $220 | $182.45 | +20.58% | 6 | Jul 6, 2026 | |
| ORKA Oruka Therapeutics | Rated: Buy | $100 → $130 | $94.79 | +37.15% | 7 | Jul 2, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $76 | $53.66 | +41.63% | 5 | Jun 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $27 | $25.03 | +7.87% | 8 | Jun 23, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $100 → $135 | $134.11 | +0.75% | 6 | Jun 23, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $25 | $23.15 | +7.99% | 17 | Jun 16, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $45 | $19.15 | +134.99% | 1 | Jun 15, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $12 | $4.25 | +182.35% | 3 | Jun 12, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $50 | $35.40 | +41.24% | 3 | Jun 9, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $145 | $127.77 | +13.49% | 5 | Jun 2, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $45 | $55.14 | -18.39% | 70 | Jun 2, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $45 | $11.28 | +298.94% | 22 | Jun 2, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $60 | $38.86 | +54.40% | 4 | May 31, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $6 | $1.93 | +210.88% | 13 | May 12, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $50 → $80 | $39.83 | +100.85% | 14 | Mar 27, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | $18 → $13 | $15.28 | -14.92% | 18 | Mar 17, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $3 → $20 | $4.60 | +334.78% | 5 | Mar 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $10 → $7 | $6.16 | +13.64% | 10 | Mar 3, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $7 | $3.79 | +84.70% | 2 | Feb 25, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $45 | $28.56 | +57.56% | 1 | Feb 17, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $45 → $50 | $19.31 | +158.93% | 2 | Jan 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $50 → $35 | $18.18 | +92.52% | 19 | Jan 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $50 → $60 | $45.85 | +30.86% | 15 | Jan 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $8 | $1.84 | +334.78% | 4 | Jan 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Hold | $30 → $28 | $25.91 | +8.07% | 5 | Jan 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $45 → $55 | $32.43 | +69.60% | 13 | Jan 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $1.5 → $3.5 | $4.17 | n/a | 8 | Jun 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $32 → $6 | $8.33 | n/a | 48 | May 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $24 → $18 | $4.32 | n/a | 3 | Mar 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $145 → $8 | $2.50 | n/a | 6 | Mar 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $3 → $1 | $14.14 | n/a | 34 | Oct 25, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $26 | $55.06 | n/a | 2 | Mar 22, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $46 → $10 | $0.5516 | n/a | 4 | Dec 22, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $45 → $15 | $6.76 | n/a | 19 | Aug 10, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $10 → $7 | $25.36 | n/a | 8 | Dec 21, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $40 → $31 | $150,000.00 | n/a | 3 | Dec 21, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $3.5 | $1.33 | n/a | 1 | Jul 8, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $22 | $5.23 | n/a | 1 | Jul 8, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $1.5 → $1 | $4.34 | n/a | 3 | Jul 8, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $47 | $2.75 | n/a | 2 | Oct 27, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $2.5 | $0.0001 | n/a | 2 | Oct 2, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $116 | $60.00 | n/a | 59 | Sep 25, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $47 | $25.61 | n/a | 2 | Sep 4, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $7 | $7.82 | n/a | 1 | Sep 4, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $5 | $37.43 | n/a | 1 | Sep 4, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $110 | $516.31 | n/a | 43 | Feb 23, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $626 | $759.24 | n/a | 43 | Jan 3, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $57 | $7.69 | n/a | 9 | Dec 30, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $25 | $1.48 | n/a | 1 | Dec 20, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $113 | $118.43 | n/a | 9 | Nov 14, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $48 | $107.12 | n/a | 1 | Oct 2, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $28 | $48.43 | n/a | 1 | Oct 2, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $133 | $254.41 | n/a | 1 | Oct 2, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $95 | $86.68 | n/a | 1 | Oct 2, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $129 | $341.20 | n/a | 1 | Oct 2, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $115 | $211.21 | n/a | 1 | Jul 28, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $12 → $2 | $0.0001 | n/a | 5 | Jun 15, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $85 → $75 | $34.46 | n/a | 7 | Apr 20, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $15 | $15.88 | n/a | 2 | Feb 5, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $157 | $415.36 | n/a | 1 | Jan 25, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $193 | $382.77 | n/a | 1 | Jan 25, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $7 | $3.98 | n/a | 2 | Jan 4, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $35 → $20 | $4.36 | n/a | 8 | Nov 6, 2015 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $9 | $86.01 | n/a | 4 | Aug 5, 2015 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | $40 | $3.02 | n/a | 4 | Jun 30, 2014 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | n/a | $141.85 | n/a | 1 | Jun 29, 2012 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $28 | $0.006 | n/a | 2 | Mar 20, 2012 |
Bristol-Myers Squibb Company
Jul 31, 2026
Maintained: Buy
Price Target: $70 → $80
Current: $65.47
Upside: +22.19%
Biogen
Jul 30, 2026
Maintained: Buy
Price Target: $225 → $240
Current: $201.82
Upside: +18.92%
Gilead Sciences
Jul 28, 2026
Maintained: Buy
Price Target: $175
Current: $131.15
Upside: +33.44%
Vertex Pharmaceuticals
Jul 28, 2026
Maintained: Buy
Price Target: $585
Current: $470.72
Upside: +24.28%
MBX Biosciences
Jul 24, 2026
Reiterated: Buy
Price Target: $60 → $90
Current: $64.41
Upside: +39.73%
Amgen
Jul 13, 2026
Rated: Buy
Price Target: $400 → $420
Current: $378.87
Upside: +10.86%
Eli Lilly and Company
Jul 13, 2026
Rated: Buy
Price Target: $1,250 → $1,425
Current: $1,121.36
Upside: +27.08%
AbbVie
Jul 13, 2026
Rated: Hold
Price Target: $230 → $260
Current: $245.10
Upside: +6.08%
Revolution Medicines
Jul 6, 2026
Reiterated: Buy
Price Target: $175 → $220
Current: $182.45
Upside: +20.58%
Oruka Therapeutics
Jul 2, 2026
Rated: Buy
Price Target: $100 → $130
Current: $94.79
Upside: +37.15%
Jun 30, 2026
Maintained: Buy
Price Target: $76
Current: $53.66
Upside: +41.63%
Jun 23, 2026
Maintained: Hold
Price Target: $27
Current: $25.03
Upside: +7.87%
Jun 23, 2026
Downgraded: Hold
Price Target: $100 → $135
Current: $134.11
Upside: +0.75%
Jun 16, 2026
Maintained: Buy
Price Target: $25
Current: $23.15
Upside: +7.99%
Jun 15, 2026
Initiated Coverage: Buy
Price Target: $45
Current: $19.15
Upside: +134.99%
Jun 12, 2026
Initiated Coverage: Buy
Price Target: $12
Current: $4.25
Upside: +182.35%
Jun 9, 2026
Reiterated: Buy
Price Target: $50
Current: $35.40
Upside: +41.24%
Jun 2, 2026
Maintained: Buy
Price Target: $145
Current: $127.77
Upside: +13.49%
Jun 2, 2026
Maintained: Hold
Price Target: $45
Current: $55.14
Upside: -18.39%
Jun 2, 2026
Maintained: Buy
Price Target: $45
Current: $11.28
Upside: +298.94%
May 31, 2026
Maintained: Buy
Price Target: $60
Current: $38.86
Upside: +54.40%
May 12, 2026
Maintained: Buy
Price Target: $6
Current: $1.93
Upside: +210.88%
Mar 27, 2026
Maintained: Buy
Price Target: $50 → $80
Current: $39.83
Upside: +100.85%
Mar 17, 2026
Rated: Hold
Price Target: $18 → $13
Current: $15.28
Upside: -14.92%
Mar 5, 2026
Maintained: Buy
Price Target: $3 → $20
Current: $4.60
Upside: +334.78%
Mar 3, 2026
Maintained: Hold
Price Target: $10 → $7
Current: $6.16
Upside: +13.64%
Feb 25, 2026
Maintained: Buy
Price Target: $7
Current: $3.79
Upside: +84.70%
Feb 17, 2026
Initiated Coverage: Buy
Price Target: $45
Current: $28.56
Upside: +57.56%
Jan 7, 2026
Initiated Coverage: Buy
Price Target: $45 → $50
Current: $19.31
Upside: +158.93%
Jan 7, 2026
Initiated Coverage: Buy
Price Target: $50 → $35
Current: $18.18
Upside: +92.52%
Jan 7, 2026
Initiated Coverage: Buy
Price Target: $50 → $60
Current: $45.85
Upside: +30.86%
Jan 6, 2026
Initiated Coverage: Buy
Price Target: $8
Current: $1.84
Upside: +334.78%
Jan 6, 2026
Initiated Coverage: Hold
Price Target: $30 → $28
Current: $25.91
Upside: +8.07%
Jan 6, 2026
Initiated Coverage: Buy
Price Target: $45 → $55
Current: $32.43
Upside: +69.60%
Jun 25, 2025
Maintained: Hold
Price Target: $1.5 → $3.5
Current: $4.17
Upside: n/a
May 27, 2025
Downgraded: Hold
Price Target: $32 → $6
Current: $8.33
Upside: n/a
Mar 13, 2025
Maintained: Buy
Price Target: $24 → $18
Current: $4.32
Upside: n/a
Mar 6, 2025
Maintained: Buy
Price Target: $145 → $8
Current: $2.50
Upside: n/a
Oct 25, 2023
Downgraded: Hold
Price Target: $3 → $1
Current: $14.14
Upside: n/a
Mar 22, 2023
Maintained: Buy
Price Target: $26
Current: $55.06
Upside: n/a
Dec 22, 2021
Downgraded: Hold
Price Target: $46 → $10
Current: $0.5516
Upside: n/a
Aug 10, 2021
Maintained: Hold
Price Target: $45 → $15
Current: $6.76
Upside: n/a
Dec 21, 2020
Maintained: Hold
Price Target: $10 → $7
Current: $25.36
Upside: n/a
Dec 21, 2018
Maintained: Buy
Price Target: $40 → $31
Current: $150,000.00
Upside: n/a
Jul 8, 2018
Reiterated: Hold
Price Target: $3.5
Current: $1.33
Upside: n/a
Jul 8, 2018
Reiterated: Buy
Price Target: $22
Current: $5.23
Upside: n/a
Jul 8, 2018
Reiterated: Hold
Price Target: $1.5 → $1
Current: $4.34
Upside: n/a
Oct 27, 2017
Reiterated: Buy
Price Target: $47
Current: $2.75
Upside: n/a
Oct 2, 2017
Reiterated: Hold
Price Target: $2.5
Current: $0.0001
Upside: n/a
Sep 25, 2017
Reiterated: Buy
Price Target: $116
Current: $60.00
Upside: n/a
Sep 4, 2017
Reiterated: Buy
Price Target: $47
Current: $25.61
Upside: n/a
Sep 4, 2017
Reiterated: Buy
Price Target: $7
Current: $7.82
Upside: n/a
Sep 4, 2017
Reiterated: Buy
Price Target: $5
Current: $37.43
Upside: n/a
Feb 23, 2017
Reiterated: Hold
Price Target: $110
Current: $516.31
Upside: n/a
Jan 3, 2017
Reiterated: Buy
Price Target: $626
Current: $759.24
Upside: n/a
Dec 30, 2016
Reiterated: Hold
Price Target: $57
Current: $7.69
Upside: n/a
Dec 20, 2016
Reiterated: Buy
Price Target: $25
Current: $1.48
Upside: n/a
Nov 14, 2016
Reiterated: Buy
Price Target: $113
Current: $118.43
Upside: n/a
Oct 2, 2016
Reiterated: Buy
Price Target: $48
Current: $107.12
Upside: n/a
Oct 2, 2016
Reiterated: Buy
Price Target: $28
Current: $48.43
Upside: n/a
Oct 2, 2016
Reiterated: Buy
Price Target: $133
Current: $254.41
Upside: n/a
Oct 2, 2016
Reiterated: Buy
Price Target: $95
Current: $86.68
Upside: n/a
Oct 2, 2016
Reiterated: Buy
Price Target: $129
Current: $341.20
Upside: n/a
Jul 28, 2016
Maintained: Buy
Price Target: $115
Current: $211.21
Upside: n/a
Jun 15, 2016
Downgraded: Hold
Price Target: $12 → $2
Current: $0.0001
Upside: n/a
Apr 20, 2016
Reiterated: Buy
Price Target: $85 → $75
Current: $34.46
Upside: n/a
Feb 5, 2016
Reiterated: Hold
Price Target: $15
Current: $15.88
Upside: n/a
Jan 25, 2016
Reiterated: Buy
Price Target: $157
Current: $415.36
Upside: n/a
Jan 25, 2016
Reiterated: Buy
Price Target: $193
Current: $382.77
Upside: n/a
Jan 4, 2016
Reiterated: Hold
Price Target: $7
Current: $3.98
Upside: n/a
Nov 6, 2015
Reiterated: Buy
Price Target: $35 → $20
Current: $4.36
Upside: n/a
Aug 5, 2015
Maintained: Hold
Price Target: $9
Current: $86.01
Upside: n/a
Jun 30, 2014
Rated: Hold
Price Target: $40
Current: $3.02
Upside: n/a
Jun 29, 2012
Upgraded: Buy
Price Target: n/a
Current: $141.85
Upside: n/a
Mar 20, 2012
Maintained: Buy
Price Target: $28
Current: $0.006
Upside: n/a